Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 341-350 of 409 for center for individualized medicine

Edit search filters
  1. Clinical and Basic Investigations into Congenital Disorders of Glycosylation

    Jacksonville, FL, Rochester, MN

  2. Determining the Special Gene Expressions in Patients with Lung Cancer or Mesothelioma

    Rochester, MN

  3. Biomarker Feedback to Motivate Tobacco Cessation in Pregnant Alaska Native Women

    Rochester, MN

  4. A Study To Increase Understanding About Pancreatic Cancer Genetics And Response To Drug Therapy

    Rochester, MN

  5. Exploring Duodenal Biopsies As A Biomarker Of Pancreatic Cancer

    Rochester, MN

  6. A Study To Assess Monoclonal B-cell Lymphocytosis In Individuals With Chronic Hepatitis C

    Rochester, MN

  7. A Study to Evaluate Screening Contrast Enhanced Digital Mammogram (CEDM) in Study Participants at Intermediate Breast Cancer Risk and Polygenic Risk Score (PRS) Results

    Rochester, MN

  8. Transplant Organ Genomics to Help Prevent Rejection in Kidney Transplant Recipients – RNA-seq Signature Validation

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  9. A Study to Collect Maternal Blood Samples to Isolate DNA for Prenatal Screening (NIPS) in Patients Undergoing Prenatal Chromosomal Testing

    Rochester, MN

  10. Genotype-Phenotype Correlation in Cardiovascular Disease

    Rochester, MN

.

Mayo Clinic Footer